描述
Revolade 50mg Tablet是一种含有活性成分厄曲培肽的药物。它用于治疗特定类型的贫血,特别是成人和儿童的慢性免疫性血小板减少症(ITP),以及对其他治疗方案未应答的成人严重骨髓抑制性贫血。厄曲培肽通过刺激骨髓生成更多血小板起作用。通常每天口服一次。常见的副作用可能包括恶心、呕吐、腹泻、肌肉疼痛和头痛。少见但严重的副作用可能发生,因此如有任何疑虑,请与您的医疗提供者讨论。Revolade应储存在室温下,避免潮湿和热源,并放在儿童不易触及的地方。

Rx (Prescription Medicine)
USD $ 30.00
Revolade 50mg Tablet是一种含有活性成分厄曲培肽的药物。它用于治疗特定类型的贫血,特别是成人和儿童的慢性免疫性血小板减少症(ITP),以及对其他治疗方案未应答的成人严重骨髓抑制性贫血。厄曲培肽通过刺激骨髓生成更多血小板起作用。通常每天口服一次。常见的副作用可能包括恶心、呕吐、腹泻、肌肉疼痛和头痛。少见但严重的副作用可能发生,因此如有任何疑虑,请与您的医疗提供者讨论。Revolade应储存在室温下,避免潮湿和热源,并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 Eltrombopag 50 Mg — 同一活性成分且强度相同,但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.